February 2021 newsletter
Streamline design for covalent inhibitors Medicinal chemistry has renewed its interest in targeted covalent inhibitors. Explore how the covalent docking workflow ...
Understanding SAR is fundamental in many aspects of drug discovery, from exploring chemical space to lead optimization. In this study, we use Activity Atlas™ and Activity Miner™, two modules that will soon be available in Flare™, to analyze the complex SAR of a series of benzoxazepinone RIPK1 inhibitors.
We are pleased to announce the appointment of David Newble as Non-Executive Director to advise and contribute to the continued growth of the company. David brings a wealth of experience in the life sciences, technology and services sectors.
A well-defined and managed hypothesis maximizes the chances of success and return on investment in a discovery project. Learn how Torx™ can connect all project information in a central platform, enabling teams to capture and manage hypotheses effectively and make better informed research decisions.
In this webinar, we'll explore how complementing your internal research by outsourcing all or part of your computational chemistry can be particularly successful in accelerating the commercialization of your research assets. The discussion will also explore the different ways our CADD scientists work with discovery teams to deliver their corporate objectives, including strategic contributions, written proposals, flexible service packages and monitoring and reporting on project progress. Registration is open.
Cresset scientists will present our latest science and showcase upcoming solutions to help your chemists design the best molecules as efficiently as possible. Users of our solutions will present case studies of their work. Presentations will be delivered online, over two hours, at 9am BST (10am CEST) and 5pm BST (12pm EDT, 9am PDT). View agenda, abstracts and registration.